Chronic myeloid leukemia arising from acute myeloid leukemia: response to imatinib mesylate with favorable outcome

被引：3
|
作者：
Xu, Xiao-Hua [1 ]
Huang, Lian-Sheng [1 ]
Yang, Jing [1 ]
Yu, Teng [1 ]
Tong, Jie-Feng [1 ]
Yuan, Xiang-Gui [2 ,3 ]
Zhao, Xiao-Ying [1 ]
机构：
[1] Zhejiang Univ, Dept Hematol, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Binjiang Branch, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China
[3] Hangzhou Binjiang Hosp, Dept Internal Med, Hangzhou, Zhejiang, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2013年 / 54卷 / 01期
关键词：
CHRONIC MYELOGENOUS LEUKEMIA;
D O I：
10.3109/10428194.2012.692788
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 197
页数：3
相关论文
共 50 条
  • [31] miRNA in chronic myeloid leukemia and imatinib response
    Dulucq, Stephanie
    Mahon, Francois Xavier
    PHARMACOGENOMICS, 2010, 11 (09) : 1201 - 1202
  • [32] Pharmacogenetic Markers of Treatment Response of Imatinib Mesylate in Chronic Myeloid Leukemia Brazilian Patients
    Vieira, Natlia M.
    Leite, Renata
    Reginato, Fabiola
    Zandona, Marilia
    Costa, Tito Vanelli
    Fogliatto, Laura
    Linden, Rafael
    Antunes, Marina Venzon
    Capron, Arnaud
    Wallemacq, Pierre
    Wagner, Sandrine
    Mattevi, Vanessa
    Capra, Marcelo
    BLOOD, 2016, 128 (22)
  • [33] Evaluation of Molecular Response to Imatinib Mesylate Treatment in Iranian Patients With Chronic Myeloid Leukemia
    Nekoohesh, Ladan
    Rostami, Shahrbano
    Nikbakht, Mohsen
    Mohammadi, Saeed
    Babakhani, Davood
    Alimoghaddam, Kamran
    Ghahremani, Mohammad H.
    Chahardouli, Bahram
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (01): : E1 - E10
  • [34] Impact of quantitative molecular response on the evolution of chronic myeloid leukemia treated with imatinib mesylate
    Nicolini, Franck
    HEMATOLOGIE, 2006, 12 (04): : 226 - 227
  • [35] Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia
    Courville, Elizabeth L.
    Wu, Yue
    Kourda, Jihen
    Roth, Christine G.
    Brockmann, Jillian
    Muzikansky, Alona
    Fathi, Amir T.
    de Leval, Laurence
    Orazi, Attilio
    Hasserjian, Robert P.
    MODERN PATHOLOGY, 2013, 26 (06) : 751 - 761
  • [36] Acute Basophilic Leukemia Arising from Chronic Myeloid Leukemia with Isolated Thrombocytosis
    Zhang, Yun
    Kang, Xiaosu
    Chen, Xiliang
    Li, Ting
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (04) : 341 - 343
  • [37] Imatinib mesylate can induce molecular remissions in chronic myeloid leukemia
    Lawler, M
    Gately, K
    Ryan, J
    Carroll, P
    Howard, J
    Stallings, R
    Conneally, E
    McCann, S
    BONE MARROW TRANSPLANTATION, 2003, 31 : S160 - S160
  • [38] Drug Efflux Transporters and Imatinib Mesylate Insensitivity in Chronic Myeloid Leukemia
    Aquino Moreira-Nunes, Caroline Fatima
    Simoes Beltrao, Ana Cristina
    Valente Martins Frances, Larissa Tatiana
    Mattos Amaral Sousa, Rodrigo Guarischi
    Silva, Israel Tojal
    Silva, Artur Luiz
    Silva-, Wilson Araujo, Jr.
    Rodrigues Lemos, Jose Alexandre
    BLOOD, 2012, 120 (21)
  • [39] IMATINIB MESYLATE INDUCED HEPATOTOXICITY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)
    Milosevic, V.
    Bogdanovic, A.
    Djordjevic, V.
    Fekete, M. Dencic
    Mihaljevic, B.
    Gotic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 545 - 546
  • [40] Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate
    Arora, B
    Kumar, L
    Sharma, A
    Wadhwa, J
    Kochupillai, V
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 358 - 359
12345